Joseph Monahan
Chief Tech/Sci/R&D Officer en ACLARIS THERAPEUTICS, INC. .
Fortuna: 231 850 $ al 31/03/2024
Cargos activos de Joseph Monahan
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - | - |
Aclaris Life Sciences, Inc.
 Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Director/Board Member | 01/01/2010 | - |
| Chief Tech/Sci/R&D Officer | 01/01/2010 | - | |
| Founder | 01/01/2010 | - |
Historial de carrera de Joseph Monahan
Antiguos cargos conocidos de Joseph Monahan.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Formación de Joseph Monahan.
| State University of New York at Buffalo | Undergraduate Degree |
| University of South Carolina | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
| Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Aclaris Life Sciences, Inc.
Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Health Services |
- Bolsa de valores
- Insiders
- Joseph Monahan
- Experiencia
